https://www.trestlewire.com/article/fda-approves-inovio-voceryq-dna-immunotherapy-respiratory-papillomatosis Trestlewire en 2026-11-01T15:04:03.427+00:00 FDA approves Inovio's Voceryq, first DNA immunotherapy for adults with recurrent respiratory papillomatosis https://www.trestlewire.com/article/scribd-security-incident-notice-email-payment-history Trestlewire en 2026-10-31T21:20:56.15+00:00 Scribd tells users a breach exposed emails and partial card details